Skip to main content
Top

2011 | OriginalPaper | Hoofdstuk

27. Kiemceltumoren van de testis

Auteurs : Prof. dr. J. A. Gietema, Prof. dr. A. J. H. Suurmeijer, Prof. dr. H. J. Hoekstra

Gepubliceerd in: Oncologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Hoewel testistumoren zeldzaam zijn, is het carcinoom uitgaande van het kiemepitheel van de testis het meest voorkomende carcinoom bij jonge mannen. Dit over het algemeen zeer maligne carcinoom metastaseert snel, maar het overgrote deel van de patiënten kan desondanks worden gecureerd.
Literatuur
go back to reference Belt-Dusebout AW van den, Wit R de, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-8.CrossRefPubMed Belt-Dusebout AW van den, Wit R de, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-8.CrossRefPubMed
go back to reference Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA 2008;299:672-84.CrossRefPubMed Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA 2008;299:672-84.CrossRefPubMed
go back to reference Horwich A, Shipley J, Huddart RA. Testicular germ-cell cancer. Lancet 2006;367:754-65.PubMed Horwich A, Shipley J, Huddart RA. Testicular germ-cell cancer. Lancet 2006;367:754-65.PubMed
go back to reference IGCCCG, International Germ Cell Consensus Classification Group. A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.CrossRef IGCCCG, International Germ Cell Consensus Classification Group. A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.CrossRef
go back to reference Jones RH, Vasey PA. I Testicular cancer, management of early disease. The Lancet Oncology 2003;4:730-7.CrossRefPubMed Jones RH, Vasey PA. I Testicular cancer, management of early disease. The Lancet Oncology 2003;4:730-7.CrossRefPubMed
go back to reference Jones RH, Vasey PA. II Testicular cancer, management of advanced disease. The Lancet Oncology 2003;4:738-47.CrossRefPubMed Jones RH, Vasey PA. II Testicular cancer, management of advanced disease. The Lancet Oncology 2003;4:738-47.CrossRefPubMed
go back to reference Jonker-Pool G, Wiel HB van de, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer, review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sexual Behavior 2001;30:55-74.CrossRef Jonker-Pool G, Wiel HB van de, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer, review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sexual Behavior 2001;30:55-74.CrossRef
go back to reference Mead GM. Who should manage germ cell tumours of the testis. BJU Int 1999;89:61-7.CrossRef Mead GM. Who should manage germ cell tumours of the testis. BJU Int 1999;89:61-7.CrossRef
go back to reference Meinardi MT, Gietema JA, Graaf WT van der, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000;18:1725-32.CrossRefPubMed Meinardi MT, Gietema JA, Graaf WT van der, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000;18:1725-32.CrossRefPubMed
go back to reference Nuver J, Smit AJ, Wolffenbuttel BH, et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718-25.CrossRefPubMed Nuver J, Smit AJ, Wolffenbuttel BH, et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718-25.CrossRefPubMed
go back to reference Shelley MD, Burgon K, Mason MD. Treatment of testicular germ-cell cancer: a Cochrane evidence-based systematic review. Cancer Treatm Reviews 2002;28:237-53.CrossRef Shelley MD, Burgon K, Mason MD. Treatment of testicular germ-cell cancer: a Cochrane evidence-based systematic review. Cancer Treatm Reviews 2002;28:237-53.CrossRef
go back to reference Wit R de, Roberts JT, Wilkinson PM, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomised study of the European Organisation for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001;19:1629-40.CrossRefPubMed Wit R de, Roberts JT, Wilkinson PM, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomised study of the European Organisation for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001;19:1629-40.CrossRefPubMed
go back to reference Wit R de, Stoter G. Behandeling van gemetastaseerd testiscarcinoom, naar prognose, en nieuwe ontwikkelingen. Ned Tijdschr Geneesk 2001;145:1194-9. Wit R de, Stoter G. Behandeling van gemetastaseerd testiscarcinoom, naar prognose, en nieuwe ontwikkelingen. Ned Tijdschr Geneesk 2001;145:1194-9.
Metagegevens
Titel
Kiemceltumoren van de testis
Auteurs
Prof. dr. J. A. Gietema
Prof. dr. A. J. H. Suurmeijer
Prof. dr. H. J. Hoekstra
Copyright
2011
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8476-1_27